TT
Terveystalo Oyj
TTALF · OTC
$11.00 +22.91% (+$2.05)
Market Cap 988.8M €
P/E Ratio 14.52x
Div. Yield 7.31%
ROE 12.38%
Bulios Fair Price
$12.84
16.7% upside
Current Price
$11
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TTALF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
95 /100
Cheap P/FCF 7.65x
P/E 14.52x
P/B 1.86x
Growth
65 /100
Stable FCF growth 24.15%
EPS growth 56.62%
Book val. growth 0.45%
Profitability
50 /100
Moderate Op. margin 8.70%
Gross margin 29.46%
FCF margin 10.65%
Quality
50 /100
Average ROA 4.73%
ROIC 6.86%
Asset turnover 0.84x
Debt
42 /100
Moderate Int. coverage 4.77x
Debt/Equity 1.22x
Net debt/EBITDA 2.72x
Stability
46 /100
Moderate EPS volatility 273.70%
Beta 0.37x
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TTALF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Ville Iho
Employees
8,356
Headquarters
Helsinki
Upcoming events
08 OCT
Ex-Dividend
Ex-dividend date
15 OCT
Dividend Payment
Payment date
21 OCT
Earnings
Upcoming earnings report